THC — THC Biomed Intl Cashflow Statement
0.000.00%
Last trade - 00:00- CA$3.38m
- CA$7.98m
- CA$3.34m
Annual cashflow statement for THC Biomed Intl, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2018 July 31st | 2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.5 | -12.7 | -0.162 | -6.36 | -3.07 |
| Depreciation | |||||
| Non-Cash Items | 10.7 | 10.2 | -1.41 | 3.62 | 0.74 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.826 | 0.002 | 0.675 | 0.75 | -0.46 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -2.43 | -1.87 | 0.115 | -1.01 | -1.86 |
| Capital Expenditures | -5.13 | -7.16 | -1.43 | -0.369 | -0.16 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.071 | 0.007 | -0.083 | -0.028 | 2.64 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.06 | -7.15 | -1.51 | -0.397 | 2.48 |
| Financing Cash Flow Items | -0.45 | 0.475 | -0.081 | 0 | 0.029 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.48 | 8 | 1.16 | 0.767 | -0.25 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.98 | -1.02 | -0.24 | -0.64 | 0.373 |